Status:
COMPLETED
Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Fever
Bacterial Infection
Eligibility:
All Genders
7-3 years
Brief Summary
The primary objective is to study the value of serum procalcitonin as a predictive marker for severe bacterial infection in febrile infants. 2200 febrile infants aged less than 3 months will prospect...
Detailed Description
Serious bacterial infections are often difficult to detect in infant with fever without source. Procalcitonin is a better blood marker of infection than White blood cell count and possibly than C-reac...
Eligibility Criteria
Inclusion
- Infant older than 7 days old and less than 3 months old.
- Fever (defined by a rectal temperature greater than or equal to 38°C)
- Emergency consultation
Exclusion
- Infants with a previously identified immunodeficiency or chronic disease,
- Antibiotic treatment within the previous 48 hours
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
2209 Patients enrolled
Trial Details
Trial ID
NCT00800488
Start Date
October 1 2008
End Date
April 1 2011
Last Update
July 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Emergency Depatment - Hôpital Antoine Béclère
Clamart, Hauts-de-Seine, France, 92140